Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)
Polaris Group
Polaris Group
Advenchen Laboratories, LLC
Intensity Therapeutics, Inc.
Eli Lilly and Company
Rain Oncology Inc
ImmunityBio, Inc.
Philogen S.p.A.
Eisai Inc.
Gradalis, Inc.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Xian-Janssen Pharmaceutical Ltd.
Threshold Pharmaceuticals
Sanofi
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Pfizer
Merck Sharp & Dohme LLC
INSYS Therapeutics Inc
GlaxoSmithKline
Alaunos Therapeutics